Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial.
Day DG, Walters TR, Schwartz GF, Mundorf TK, Liu C, Schiffman RM, Bejanian M. Day DG, et al. Among authors: mundorf tk. Br J Ophthalmol. 2013 Aug;97(8):989-93. doi: 10.1136/bjophthalmol-2012-303040. Epub 2013 Jun 6. Br J Ophthalmol. 2013. PMID: 23743437 Free PMC article. Clinical Trial.
Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S, Mundorf TK, Stewart JA, Stewart WC. Sonty S, et al. Among authors: mundorf tk. Clin Ther. 2009 Oct;31(10):2063-71. doi: 10.1016/j.clinthera.2009.10.003. Clin Ther. 2009. PMID: 19922877 Clinical Trial.
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page